# Isolation and characterization of antiplasmodial and antimicrobial compounds from Tetracera alnifolia using a bioassay-guided approach

**Authors:** Mamadou Aliou Baldé, Mohamed Sahar Traoré, Mamadou Saliou Telly Diallo, An Matheeussen, Camara Aïssata, Paul Cos, Louis Maes, Alpha Oumar Baldé, Mohamed Kerfala Camara, Aliou Mamadou Balde, Emmy Tuenter, Kenn Foubert

PMC · DOI: 10.1039/d5ra09498d · RSC Advances · 2026-02-23

## TL;DR

Scientists isolated and tested compounds from Tetracera alnifolia leaves that show antiplasmodial effects but not antifungal activity.

## Contribution

The study identifies specific antiplasmodial compounds in Tetracera alnifolia using bioassay-guided fractionation.

## Key findings

- Pheophorbide-b methyl ester, isophytol, and phytol showed the strongest antiplasmodial activity.
- None of the compounds exhibited antifungal activity against Candida albicans.
- Some compounds, like pheophorbide-b methyl ester, showed high cytotoxicity.

## Abstract

A preliminary biological screening demonstrated that leaf extracts from Tetracera alnifolia exhibit promising activity against Plasmodium falciparum and Candida albicans. To identify the constituents responsible for these effects, a bioassay-guided fractionation strategy was subsequently employed. Fractions were purified using flash chromatography, followed by semi-preparative HPLC-DAD-MS and LC-SPE-NMR. Structural elucidation of the isolated compounds was accomplished through comprehensive 1D and 2D NMR analyses in combination with HR-ESI-MS. The purified metabolites were subsequently evaluated for their bioactivity against Plasmodium falciparum and Candida albicans, and their cytotoxicity was assessed in MRC-5SV2 human foetal lung fibroblast cells. In total, nineteen compounds (1–19) were isolated from T. alnifolia leaves. Among these, the strongest antiplasmodial activities were observed for pheophorbide-b methyl ester (1.0 ± 0.7 µM), (1,2)-bis-nor-phytone (2.0 µM), isophytol (4.0 µM), pheophorbide-a methyl ester (2.8 ± 1.2 µM), epicatechin-3-galloyl ester (5.5 ± 2.1 µM), and phytol (6.9 ± 2.4 µM). Other compounds, including myricetin-3-O-rhamnopyranoside, α-tocopherol and cycloart-24-en-3β-yl α-linolenate, exhibited lower activity, with IC50 values ranging from 13.5 to 25 µM. None of the evaluated compounds showed antifungal activity against C. albicans. Notably, high cytotoxicity was observed for pheophorbide-b methyl ester, pheophorbide-a methyl ester, and phytol. These findings provide insight into the constituents that underlie the antiplasmodial activity of T. alnifolia leaf extracts.

Bioassay-guided fractionation workflow of T. alnifolia leaf extracts leading to the isolation of active compounds against Plasmodium falciparum and Candida albicans.

## Linked entities

- **Chemicals:** isophytol (PubChem CID 10453), pheophorbide-a methyl ester (PubChem CID 162829881), epicatechin-3-galloyl ester (PubChem CID 107905), phytol (PubChem CID 5280435), myricetin-3-O-rhamnopyranoside (PubChem CID 5281673), α-tocopherol (PubChem CID 2116)

## Full-text entities

- **Genes:** HSD17B8 (hydroxysteroid 17-beta dehydrogenase 8) [NCBI Gene 7923] {aka D6S2245E, FABG, FABGL, H2-KE6, HKE6, KE6}, NAA10 (N-alpha-acetyltransferase 10, NatA catalytic subunit) [NCBI Gene 8260] {aka ARD1, ARD1A, ARD1P, DXS707, LZMS, MAA}
- **Diseases:** oral diseases (MESH:D009059), inflammation (MESH:D007249), pain (MESH:D010146), skin diseases (MESH:D012871), sexually transmitted infections (MESH:D012749), cancer (MESH:D009369), malaria (MESH:D008288), infectious diseases (MESH:D003141), leprosy (MESH:D007918), infections (MESH:D007239), Cytotoxicity (MESH:D064420), cough (MESH:D003371)
- **Chemicals:** H2O (MESH:D014867), D2O (MESH:D017666), pheophorbide-a (MESH:C032623), myricetin (MESH:C040015), vanillin (MESH:C100058), terpenoids (MESH:D013729), squalene (MESH:D013185), essential oil (MESH:D009822), epicatechin (MESH:D002392), epicatechin-3-galloyl ester (MESH:C062669), aglycone (MESH:C458179), ethanol (MESH:D000431), aldehyde (MESH:D000447), 13C (MESH:C000615229), tetrapyrrole (MESH:D045725), doxycycline (MESH:D004318), silica gel (MESH:D058428), methanol (MESH:D000432), abscisic acid (MESH:D000040), poly(divinylbenzene (MESH:C056745), Formic acid (MESH:C030544), n-hexane (MESH:C026385), Phytol (MESH:D010836), gallic acid (MESH:D005707), vanillic acid (MESH:D014641), tamoxifen (MESH:D013629), Flucytosine (MESH:D005437), CH2Cl2 (MESH:D008752), Quercetin (MESH:D011794), nitrogen (MESH:D009584), chlorophyll (MESH:D002734), acetonitrile (MESH:C032159), carbon (MESH:D002244), myricetin-3-O-rhamnoside (MESH:C529905), quercetin-3-O-rhamnopyranoside (MESH:C012526), alpha-tocopherol (MESH:D024502), Isophytol (MESH:C549875), flavonoids (MESH:D005419), diterpenoid (MESH:D004224), sulfuric acid (MESH:C033158), chloroquine (MESH:D002738), (1,2)-bis-nor-phytone (-), ethyl acetate (MESH:C007650), porphyrin (MESH:D011166), hexane (MESH:D006586), n-butanol (MESH:D020001), quercetin-3-O-beta-d-galactopyranoside (MESH:C508165), toluene (MESH:D014050), Myricetin-3-O-rhamnopyranoside (MESH:C008577), acetone (MESH:D000096), fatty acid (MESH:D005227)
- **Species:** Microglossa pyrifolia (species) [taxon 1898725], Brassica oleracea (wild cabbage, species) [taxon 3712], Human immunodeficiency virus 1 (no rank) [taxon 11676], Candida albicans (species) [taxon 5476], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Gaultheria alnifolia (species) [taxon 2946358], Garuga pinnata (species) [taxon 1591304], Camellia sinensis (black tea, species) [taxon 4442], Tetracera (genus) [taxon 85284], Sclerocarya birrea (species) [taxon 289766], Pellia epiphylla (species) [taxon 40340], Newtonia buchananii (species) [taxon 148738], Calotropis procera (species) [taxon 141467], Staphylococcus aureus (species) [taxon 1280], Strobilanthes crispa (species) [taxon 946018], Plasmodium falciparum K1 (strain) [taxon 5839], Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833], Homo sapiens (human, species) [taxon 9606], Plasmodium falciparum 3D7 (isolate) [taxon 36329]
- **Cell lines:** 3D7 — Mus musculus (Mouse), Hybridoma (CVCL_KS87), MRC-5SV2 — Homo sapiens (Human), Transformed cell line (CVCL_2627), D10 — Mus musculus (Mouse), Factor-dependent cell line (CVCL_0241), NF54 — Homo sapiens (Human), Ovarian carcinosarcoma, Cancer cell line (CVCL_W770), ATCC 6538 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), K1 — Equus caballus (Horse), Induced pluripotent stem cell (CVCL_C7F1), Dd2 — Cricetulus griseus (Chinese hamster), Transformed cell line (CVCL_YD16), FCR-1/FVO — Canis lupus familiaris (Dog), Canine histiocytic sarcoma, Cancer cell line (CVCL_IU61)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926867/full.md

## Figures

20 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926867/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926867/full.md

---
Source: https://tomesphere.com/paper/PMC12926867